×

Food and Staples Retailing Drug Retail

  • Short seller takes aim at Express Scripts

    Shares of Express Scripts plunge following short-seller Andrew Left's series of tweets taking aim at the company. CNBC's Meg Tirrell reports.

  • Funtleyder: Healthcare, unlike rest of markets, is in a holding pattern

    Les Funtleyder, ESquared Asset Management, weighs in on Donald Trump's attack against drug prices, and the healthcare sector.

  • Jim O'Neill considered for FDA commissioner

    CNBC's Meg Tirrell reports on who may be leading the FDA under a Trump presidency.

  • Meekins: Don't read much into Trump drug pricing comments

    Chris Meekins, FBR research analyst, discusses three reasons to ignore Donald Trump's comments against the current drug prices.

  • Kenneth Frazier, CEO of Merck.

    Kenneth Frazier, the CEO of pharmaceutical giant Merck, says Trump's call to revamp Obamacare could prove useful.

  • Bringing drugs in from outside the US is actually a dangerous concept: Merck CEO

    CNBC’s Meg Tirrell talks to Kenneth Frazier, Merck CEO, at the fifth annual Forbes Healthcare Summit in New York about the future of drug pricing under the Trump administration as well as Alzheimer’s research.

  • Nov 22- Two executives of Costco Wholesale Corp may have sought kickbacks from drug makers in violation of Ontario law, an industry regulator in the Canadian province has found as it advances a probe into the retailer's pharmacy business. The Ontario College of Pharmacists launched an investigation into the executives for alleged misconduct after a former...

  • JOHANNESBURG, Nov 18- South Africa's Dis-Chem plans to double in size over the next five years its chief executive said on Friday, as the drug store chain made its debut on the Johannesburg bourse. The company braved uncertain equity markets in South Africa's second largest listing this year after food services group Bidcorp, which made its debut in May at a...

  • JOHANNESBURG, Nov 18- South African drug store chain Dis-Chem made its debut on the Johannesburg bourse on Friday, giving its founders a chance to partially cash in on their investment and bring a rival to the main pharmacy merchant on the bourse. Founded by Chief Executive Ivan Saltzman and his wife Lynette, Dis-Chem has grown from a start-up in 1978 to a major...

  • JOHANNESBURG, Nov 18- South African drug store chain Dis-Chem made its debut on the Johannesburg bourse on Friday, with its shares opening at 23.26 rand and valuing it at around 20 billion rand. Founded by chief executive Ivan Saltzman and his wife Lynette, Dis-Chem is tapping an uncertain equity market as it looks to take on larger rival Clicks Group and...

  • The new war on drugs

    Ravi Mehrotra, MTS Partners, and CNBC's Meg Tirrell discuss the high cost of pharmaceuticals in America and what can be done to rein prices in.

  • Nov 16- Canadian grocery and pharmacy retailer Loblaw Cos Ltd reported a 25.5 percent rise in quarterly profit, helped by a drop in expenses and improved performances by its financial services and property businesses. Adjusted net earnings attributable to shareholders rose to C $512 million, or C $1.26 per share, in the third quarter ended Oct. 8, from C $408...

  • Drug pricing pressure

    CNBC's Meg Tirrell speaks with Alkermes Chairman & CEO Richard Pops at the Partnering for Cures conference about drug pricing, his company's new depression drug and the opioid epidemic.

  • A study comparing three popular arthritis drugs shows they're all about equally safe and equally dangerous for the heart, reports NBC.

  • Nov 8- CVS Health Corp, the No. 2 U.S. drugstore chain by store count, reported a 15.5 percent rise in quarterly revenue, helped by strong demand for its pharmacy benefit management services. Net income attributable to CVS rose to $1.54 billion, or $1.43 per share, in the third quarter ended Sept. 30, from $1.25 billion, or $1.11 per share, a year earlier.

  • Cali's drug price brawl

    CNBC's Meg Tirrell reports the latest surrounding California's Proposition 61.

  • New war on drugs: Pharma becoming 'uninvestable'?

    Bill George, Harvard Business School Professor and former Medtronic Chairman and CEO, and David Maris, Wells Fargo Securities Specialty Pharmaceutical Analyst, weigh in on the ongoing drug-pricing war.

  • Big pharma's big problem

    CNBC's Meg Tirrell discusses the timeline on the war on drug pricing.

  • Nov 3- CVS Health Corp said it would cut about 600 jobs, mostly at its corporate offices in Rhode Island, Illinois and Arizona over the next two months, citing an increasingly competitive environment. The drugstore chain operator, which is expected to report third-quarter results next week, employs more than 240,000 people in the United States.

  • Generic drug probe charges to be filed by year end -Rpt

    CNBC's Dominic Chu reports on possible charges being filed by the Justice Department against some generic drugmakers, according to Bloomberg.